These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 29988117)

  • 1. The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis.
    Overstreet AM; LaTorre DL; Abernathy-Close L; Murphy SF; Rhee L; Boger AM; Adlaka KR; Iverson AM; Bakke DS; Weber CR; Boone DL
    Mucosal Immunol; 2018 Sep; 11(5):1454-1465. PubMed ID: 29988117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinoid orphan receptor gamma t (rorγt) promotes inflammatory eosinophilia but is dispensable for innate immune-mediated colitis.
    Torres-Huerta A; Ruley-Haase K; Reed T; Boger-May A; Rubadeux D; Mayer L; Rajashekara AM; Hiller M; Frech M; Roncagli C; Pedersen C; Camacho MC; Hollmer L; English L; Kane G; Boone DL
    PLoS One; 2024; 19(3):e0300892. PubMed ID: 38512959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered microbial biogeography in an innate model of colitis.
    Boger-May A; Reed T; LaTorre D; Ruley-Haase K; Hoffman H; English L; Roncagli C; Overstreet AM; Boone D
    Gut Microbes; 2022; 14(1):2123677. PubMed ID: 36162004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biological Therapy in Inflammatory Bowel Disease Patients Partly Restores Intestinal Innate Lymphoid Cell Subtype Equilibrium.
    Creyns B; Jacobs I; Verstockt B; Cremer J; Ballet V; Vandecasteele R; Vanuytsel T; Ferrante M; Vermeire S; Van Assche G; Ceuppens JL; Breynaert C
    Front Immunol; 2020; 11():1847. PubMed ID: 32983101
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease.
    Saez A; Gomez-Bris R; Herrero-Fernandez B; Mingorance C; Rius C; Gonzalez-Granado JM
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Divergent Roles of Interferon-γ and Innate Lymphoid Cells in Innate and Adaptive Immune Cell-Mediated Intestinal Inflammation.
    Brasseit J; Kwong Chung CKC; Noti M; Zysset D; Hoheisel-Dickgreber N; Genitsch V; Corazza N; Mueller C
    Front Immunol; 2018; 9():23. PubMed ID: 29416538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 6 Increases Production of Cytokines by Colonic Innate Lymphoid Cells in Mice and Patients With Chronic Intestinal Inflammation.
    Powell N; Lo JW; Biancheri P; Vossenkämper A; Pantazi E; Walker AW; Stolarczyk E; Ammoscato F; Goldberg R; Scott P; Canavan JB; Perucha E; Garrido-Mesa N; Irving PM; Sanderson JD; Hayee B; Howard JK; Parkhill J; MacDonald TT; Lord GM
    Gastroenterology; 2015 Aug; 149(2):456-67.e15. PubMed ID: 25917784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, validation and implementation of an in vitro model for the study of metabolic and immune function in normal and inflamed human colonic epithelium.
    Pedersen G
    Dan Med J; 2015 Jan; 62(1):B4973. PubMed ID: 25557335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-Bet Controls Cellularity of Intestinal Group 3 Innate Lymphoid Cells.
    Schroeder JH; Meissl K; Hromadová D; Lo JW; Neves JF; Howard JK; Helmby H; Powell N; Strobl B; Lord GM
    Front Immunol; 2020; 11():623324. PubMed ID: 33603753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CCR8 Signaling
    Kang L; Schmalzl A; Leupold T; Gonzalez-Acera M; Atreya R; Neurath MF; Becker C; Wirtz S
    Front Immunol; 2020; 11():609400. PubMed ID: 33613532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-27 Is a Potential Rescue Therapy for Acute Severe Colitis Through Interleukin-10-Dependent, T-Cell-Independent Attenuation of Colonic Mucosal Innate Immune Responses.
    McLean MH; Andrews C; Hanson ML; Baseler WA; Anver MR; Senkevitch E; Staniszewska AK; Smith C; Davies LC; Hixon J; Li W; Shen W; Steidler L; Durum SK
    Inflamm Bowel Dis; 2017 Nov; 23(11):1983-1995. PubMed ID: 29019857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gpr109a Limits Microbiota-Induced IL-23 Production To Constrain ILC3-Mediated Colonic Inflammation.
    Bhatt B; Zeng P; Zhu H; Sivaprakasam S; Li S; Xiao H; Dong L; Shiao P; Kolhe R; Patel N; Li H; Levy-Bercowski D; Ganapathy V; Singh N
    J Immunol; 2018 Apr; 200(8):2905-2914. PubMed ID: 29514953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate Lymphoid Cells in Inflammatory Bowel Disease.
    Li J; Glover SC
    Arch Immunol Ther Exp (Warsz); 2018 Dec; 66(6):415-421. PubMed ID: 30155762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
    Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
    Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vancomycin pre-treatment impairs tissue healing in experimental colitis: Importance of innate lymphoid cells.
    Zhao D; Cai C; Zheng Q; Jin S; Song D; Shen J; Ran Z
    Biochem Biophys Res Commun; 2017 Jan; 483(1):237-244. PubMed ID: 28034757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor necrosis factor family member TNFSF14 (LIGHT) is required for resolution of intestinal inflammation in mice.
    Krause P; Zahner SP; Kim G; Shaikh RB; Steinberg MW; Kronenberg M
    Gastroenterology; 2014 Jun; 146(7):1752-62.e4. PubMed ID: 24560868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epithelial-intrinsic IKKα expression regulates group 3 innate lymphoid cell responses and antibacterial immunity.
    Giacomin PR; Moy RH; Noti M; Osborne LC; Siracusa MC; Alenghat T; Liu B; McCorkell KA; Troy AE; Rak GD; Hu Y; May MJ; Ma HL; Fouser LA; Sonnenberg GF; Artis D
    J Exp Med; 2015 Sep; 212(10):1513-28. PubMed ID: 26371187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiota-Induced TNF-like Ligand 1A Drives Group 3 Innate Lymphoid Cell-Mediated Barrier Protection and Intestinal T Cell Activation during Colitis.
    Castellanos JG; Woo V; Viladomiu M; Putzel G; Lima S; Diehl GE; Marderstein AR; Gandara J; Perez AR; Withers DR; Targan SR; Shih DQ; Scherl EJ; Longman RS
    Immunity; 2018 Dec; 49(6):1077-1089.e5. PubMed ID: 30552020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
    Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
    Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ILC3 function as a double-edged sword in inflammatory bowel diseases.
    Zeng B; Shi S; Ashworth G; Dong C; Liu J; Xing F
    Cell Death Dis; 2019 Apr; 10(4):315. PubMed ID: 30962426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.